Alexza Pharmaceuticals | Evaluate

November 12, 2014

Debt-funded biotechs under the spotlight

Teva partnership marks a reversal of fortune for Alexza

January 02, 2013

Pharma regulatory news over the Christmas period

May 04, 2012

Alexza faces cash squeeze as Adasuve sent another Dear John letter

December 13, 2011

Alexza's failure to win broad backing for Adasuve could be last gasp

February 02, 2011

Regulatory worries dampen enthusiasm for Map's Levadex deal

October 13, 2010

Alexza investors right to be agitated over FDA rebuff

September 20, 2010

Event - Alexza hopes for unhindered approval of inhaled antipsychotic

August 27, 2010

Cypress risks deepening disquiet with another spending spree

July 28, 2010

First half 2010 sees a return to more conventional deal values

June 22, 2010

Biovail and Valeant join forces to drive growth

Load More